| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 06/29/2006 | WO2004112693A3 Tissue protective cytokines with an extended therapeutic window |
| 06/29/2006 | WO2004093782A3 Tumor cytotoxicity induced by modulators of the cxcr4 receptor |
| 06/29/2006 | WO2004089292A3 Immunomodulatory agents for treatment of inflammatory diseases |
| 06/29/2006 | WO2004066942A3 Purification and uses of dendritic cells and monocytes |
| 06/29/2006 | WO2004066935A3 Sensitive proteasome sensor constructs and methods for their design and use |
| 06/29/2006 | US20060142571 improved ability to inhibit the replication of mutant strains of drug or multidrug resistant HIV strains; Indene/benzofuran Substituted Pyrimidines |
| 06/29/2006 | US20060142377 water-soluble carboxylic acid dimers that are thermally stable and stable toward hydrolysis, less toxicity; plasmodium protozoan parasites; human malaria and Plasmodium falciparum; leukemia, lung, colon, central nervous system, ovarian, renal, prostate, and breast cancer, melanoma |
| 06/29/2006 | US20060142320 Polymorphic forms of naltrexone |
| 06/29/2006 | US20060142315 Substituted biaryl piperazinyl-pyridine analogues |
| 06/29/2006 | US20060142278 Mitotic kinesin inhibitors |
| 06/29/2006 | US20060142271 Novel lapacho compounds and methods of use thereof |
| 06/29/2006 | US20060142252 Tubulin binding agents and corresponding prodrug constructs |
| 06/29/2006 | US20060142189 polypeptides derived from the ankyrin binding domain of the L1-cellular adhesion molecules (L1-CAM), used in the treatment of strokes,neurodegenerative disease, spinal cord and brain injuries |
| 06/29/2006 | US20060142187 Methods for modulating cell-to-cell adhesion using an agonist of C1INH-type protein activity |
| 06/29/2006 | US20060142180 Cholinergic modulation of microglial activation via alpha-7 nicotinic receptors |
| 06/29/2006 | US20060141579 Cytokine zcytor17 ligand polynucleotides |
| 06/29/2006 | US20060141479 Diagnosis, psoriasis, rheumatoid arthritis, emphysema, asthma, diabetes, autoimmune thyroiditis, inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, different types of dermatitis including allergic dermatitis, contact dermatitis, actinic keratosis, wound healing, cancer |
| 06/29/2006 | US20060141047 Methods and compositions for delivery of catecholic butanes for treatment of obesity |
| 06/29/2006 | US20060140966 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 06/29/2006 | US20060140959 Old-35, a gene associated with senescence and terminal cell differentiation, and uses thereof |
| 06/29/2006 | US20060140917 Compositions and methods for selective dissolution of nascent intravascular blood clots |
| 06/29/2006 | US20060140904 Random alkylene oxide copolymers for medical and surgical utilities |
| 06/28/2006 | EP1674102A1 Use of flibanserin in the treatment of sexual disorders |
| 06/28/2006 | EP1674079A2 Pressurised metered dose inhalers (MDI) |
| 06/28/2006 | EP1674078A2 Fast dissolving orally consumable filsm containing an ion exchange resin as a taste masking agent |
| 06/28/2006 | EP1673384A2 Nitrosated glutamic acid compounds, compositions and methods of use |
| 06/28/2006 | EP1673376A2 Treating bone-related disorders with selective androgen receptor modulators |
| 06/28/2006 | EP1673343A2 Compounds and compositions as protein kinase inhibitors |
| 06/28/2006 | EP1673097A2 A method for treating or inhibiting the effects of injuries or diseases that result in neuronal degeneration |
| 06/28/2006 | EP1673087A2 Alkoxy substituted imidazoquinolines |
| 06/28/2006 | EP1673085A2 C-met modulators and methods of use |
| 06/28/2006 | EP1673078A2 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/28/2006 | EP1673059A2 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 06/28/2006 | EP1673054A2 Transition state analog inhibitors of ricin a-chain |
| 06/28/2006 | EP1672978A2 Cobalamin conjugates for anti-tumor therapy |
| 06/28/2006 | EP1594488B1 Stabilized pharmaceutical compositions of safingol and methods of using the same |
| 06/28/2006 | EP1558199A4 Therapeutic combination of carnitine and antioxidant polyphenols |
| 06/28/2006 | EP1041990B1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 06/28/2006 | EP1007053B1 Treatment of pain |
| 06/28/2006 | CN1795185A Process for making substituted pyrazoles |
| 06/28/2006 | CN1795184A Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 06/28/2006 | CN1795009A Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 06/28/2006 | CN1795007A Methods and compositions for the treatment of gastrointestinal disorders |
| 06/28/2006 | CN1794994A Carbostyril derivatives and mood stabilizers for treating mood disorders |
| 06/28/2006 | CN1794992A Method for treating mild cognitive impairment and for preventing or delaying alzheimeracoes disease |
| 06/28/2006 | CN1794990A Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 06/28/2006 | CN1794989A N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes |
| 06/28/2006 | CN1794981A Combination of an nmda receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders |
| 06/28/2006 | CN1794977A Antimicrobial quaternary ammonium organosilane coatings |
| 06/28/2006 | CN1794963A Hemorrhoid treatment device |
| 06/28/2006 | CN1261163C Stabilization of macrolides |
| 06/28/2006 | CN1261162C Process for preparing aqueous extracts of plants and extracts obtained |
| 06/27/2006 | US7067509 An urea derivative containing amide, amine or substitued amine groups and pyrrolidine ring(s), useful for treating obesity, anxiety or depression |
| 06/27/2006 | US7067501 Phenylsulfanylphenyl and phenyloxyphenyl substituted piperazine compounds; glycine transport inhibitors; for the treatment of psychoses and convulsive disorders: epilepsy, spasticity, and myoclonus |
| 06/27/2006 | US7067493 Single dose azithromycin |
| 06/27/2006 | US7067116 Mixture of water soluble film forming polymer such as pullulan , dextromethorphan and an ion exchange resin such as Amberlite |
| 06/27/2006 | CA2195935C Streptococcus equi vaccine |
| 06/22/2006 | WO2006064381A2 Protein formulation |
| 06/22/2006 | WO2005102362A8 Use of chondroitin sulphate e (cs-e ) for the treatment diseases or conditions related to collagen fibril formation. |
| 06/22/2006 | WO2005102287A3 Pharmaceutical compositions for acute glucocorticoid therapy |
| 06/22/2006 | WO2005055924A3 Skin adherent hydrogels |
| 06/22/2006 | WO2005046615A3 Compositions for treatment of central nervous system mediated disorders |
| 06/22/2006 | WO2005025487A9 Oligonucleotides targeting prion diseases |
| 06/22/2006 | WO2005020905A3 Echogenic coatings with overcoat |
| 06/22/2006 | WO2005009376A3 Stable aluminum/zirconium antiperspirant solution |
| 06/22/2006 | WO2005004805A3 Thermally stable crystalline epirubicin hydrochloride and method of making the same |
| 06/22/2006 | WO2004071419A3 Methods and compositions for modulating glutamate transport activity in the nervous system |
| 06/22/2006 | WO2004056318A8 Method for treating amyloid disease |
| 06/22/2006 | US20060135765 Antineoplastic ether lipid compounds |
| 06/22/2006 | US20060135604 Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use |
| 06/22/2006 | US20060135525 Pyrazolopyrimidine compound and a process for preparing the same |
| 06/22/2006 | US20060135517 Imidazolopyridines and methods of making and using the same |
| 06/22/2006 | US20060135511 Benzodiazepine cgrp receptor antagonists |
| 06/22/2006 | US20060135474 Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B |
| 06/22/2006 | US20060135463 Methods and compositions for the treatment of lupus using clofarabine |
| 06/22/2006 | US20060135434 New peptides |
| 06/22/2006 | US20060134768 Erbb4 co-crystal |
| 06/22/2006 | US20060134240 Purified malted barley extract is administered for activating adenosine 5'-monophosphate-activated protein kinase |
| 06/22/2006 | US20060134233 Nitric oxide and its biomedical significance |
| 06/22/2006 | US20060134102 Lymphotoxin beta receptor agents in combination with chemotherapeutic agents |
| 06/22/2006 | US20060134099 Production of rabies antibodies in plants |
| 06/22/2006 | CA2767026A1 Protein formulation for administering an active enamel substance |
| 06/21/2006 | EP1671949A2 Substituted phenylamines and pyridinylamines |
| 06/21/2006 | EP1671651A1 Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonists |
| 06/21/2006 | EP1670817A2 Uses of spatial configuration to modulate protein function |
| 06/21/2006 | EP1670809A2 Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives |
| 06/21/2006 | EP1670780A2 Compounds and compositions as protein kinase inhibitors |
| 06/21/2006 | EP1670755A2 Pyrovalerone analogs and therapeutic uses thereof |
| 06/21/2006 | EP1670739A2 Cyclic diamines and derivatives as factor xa inhibitors |
| 06/21/2006 | EP1670540A2 Photodynamic inactivation of bacterial spores |
| 06/21/2006 | EP1670519A2 Radiolabeled thymidine solid-phase extraction purification method |
| 06/21/2006 | EP1670509A2 Multiplex vaccines |
| 06/21/2006 | EP1670508A2 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 06/21/2006 | EP1670499A2 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 06/21/2006 | EP1670491A2 Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
| 06/21/2006 | EP1670477A2 Combinations of drugs for the treatment of neoplasms |
| 06/21/2006 | EP1670476A2 Phenyl pyrrolidine ether tachykinin receptor antagonists |
| 06/21/2006 | EP1670475A2 Alaphatic pyrazinoylguanidine sodium channel blockers |
| 06/21/2006 | EP1670466A2 Preparation of 1, 6, 7- trisubstituted azabenzimidazoles as kinase inhibitors |
| 06/21/2006 | EP1670463A2 3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists |